Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
790 Views
eMediNexus 30 January 2018
Tiotropium showed the potential to reduce asthma exacerbation risk in children aged 1–5 years with persistent asthmatic symptoms not well-controlled by inhaled corticosteroids in a study reported online January 16, 2017 in the Lancet Respiratory Medicine.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}